IL2RB and neoplasm: To do this, we treated tumor-bearing mice with media (mock), Sin/LacZ, Sin/IL12, Sin/IL12 + anti- IFNγ (to block IFNγ activity), or Sin/IL12 + anti-CD122 (to deplete NK cells).